[A new benzodiazepine screened in a parallel double-blind test].
D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006998:Hypochondriasis / Q000188:drug therapy; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D010698:Phobic Disorders / Q000188:drug therapy
D014151:Anti-Anxiety Agents; D003975:Diazepam
Une nouvelle benzodiazepine, passée au crible d'un test double aveugle parallele